Sansure Biotech Past Earnings Performance
Past criteria checks 3/6
Sansure Biotech has been growing earnings at an average annual rate of 5.8%, while the Medical Equipment industry saw earnings growing at 8.9% annually. Revenues have been growing at an average rate of 17.6% per year. Sansure Biotech's return on equity is 4.8%, and it has net margins of 35.8%.
Key information
5.8%
Earnings growth rate
-4.3%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 17.6% |
| Return on equity | 4.8% |
| Net Margin | 35.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Sansure Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,006 | 360 | 0 | 0 |
| 30 Sep 23 | 3,015 | 638 | 868 | 289 |
| 30 Jun 23 | 4,188 | 904 | 930 | 321 |
| 31 Mar 23 | 5,206 | 1,345 | 949 | 334 |
| 31 Dec 22 | 6,450 | 1,937 | 0 | 0 |
| 30 Sep 22 | 5,316 | 2,084 | 599 | 276 |
| 30 Jun 22 | 5,176 | 2,247 | 568 | 235 |
| 31 Mar 22 | 4,791 | 2,272 | 499 | 208 |
| 31 Dec 21 | 4,515 | 2,243 | 507 | 187 |
| 30 Sep 21 | 4,425 | 2,361 | 464 | 111 |
| 30 Jun 21 | 4,691 | 2,506 | 566 | 106 |
| 31 Mar 21 | 5,526 | 3,046 | 672 | 95 |
| 31 Dec 20 | 4,763 | 2,617 | 627 | 83 |
| 30 Sep 20 | 3,727 | 2,034 | 575 | 76 |
| 30 Jun 20 | 2,299 | 1,263 | 355 | 50 |
| 31 Mar 20 | 683 | 233 | 211 | 40 |
| 31 Dec 19 | 365 | 39 | 161 | 39 |
| 31 Dec 18 | 303 | 7 | 134 | 35 |
| 31 Dec 17 | 225 | -11 | 105 | 28 |
Quality Earnings: 688289 has high quality earnings.
Growing Profit Margin: 688289's current net profit margins (35.8%) are higher than last year (30%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688289's earnings have grown by 5.8% per year over the past 5 years.
Accelerating Growth: 688289's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688289 had negative earnings growth (-81.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.4%).
Return on Equity
High ROE: 688289's Return on Equity (4.8%) is considered low.